MedTrace Logo

Omega-3 Fatty Acids in Treating Patients With Advanced Prostate Cancer

NCT00996749 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2018-07-03

No results posted yet for this study

Summary

This phase I trial is studying the best way to give omega-3 fatty acids in treating patients with advanced prostate cancer. Omega-3 fatty acids may slow disease progression and may be an effective treatment for patients with advanced prostate cancer

Conditions

  • Stage III Prostate Cancer

Interventions

DIETARY_SUPPLEMENT

omega-3 fatty acid

Given PO

OTHER

bone scan

Correlative studies

OTHER

dual x-ray absorptometry

Correlative studies

OTHER

laboratory biomarker analysis

Correlative studies

PROCEDURE

biopsy

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University Health Sciences

    lead OTHER

Principal Investigators

  • Majid Mirzazadeh · Wake Forest University Health Sciences

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00996749 on ClinicalTrials.gov